Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza Added to High-Dose Insulin in Type 2 Diabetes
NCT01654120Phase 4Completed
- Sponsor
- Mountain Diabetes and Endocrine Center
- Start
- Dec 2011
- Primary completion
- Nov 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Mountain Diabetes and Endocrine Center. Primary endpoint: Hemoglobin A1c at 6 months. Started Dec 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01654120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654120.